VincentCharlesMarconiMD
Infectious Disease • Decatur, GAProfessor, Medicine, Emory University School of Medicine
Dr. Marconi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1670 Clairmont Rd
Decatur, GA 30033Phone+1 404-321-6111
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2003 - 2005
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
GA State Medical License 2009 - 2027
MA State Medical License 2002 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Commitment Device for Medication Adherence Among HIV Patients Start of enrollment: 2011 Oct 01
- Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure Start of enrollment: 2014 Dec 01
- Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Start of enrollment: 2018 Oct 15
Publications & Presentations
PubMed
- Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV.Kartavya J Vyas, Vincent C Marconi, Brian K Agan, Patrick S Sullivan, Robert H Lyles
AIDS. 2025-04-01 - Aberrant DNA methylation of genes regulating CD4+ T cell HIV-1 reservoir in women with HIV.Ke Xu, Xinyu Zhang, Kesava Asam, Bryan C Quach, Grier P Page
Clinical and Translational Medicine. 2025-03-01 - 2 citations2024 Update of the RECOVER-Adult Long COVID Research Index.Linda N Geng, Kristine M Erlandson, Mady Hornig, Rebecca Letts, Caitlin Selvaggi
JAMA. 2025-02-25
Press Mentions
Third Transplant Patient Cured of HIV Marks Important FirstsFebruary 16th, 2022- Study Shows Benefit of Baricitinib for Ventilated COVID PatientsFebruary 14th, 2022
- Emory Launches Study to Understand Long COVID-19 as Part of a Nationwide InitiativeNovember 4th, 2021
- Join now to see all
Grant Support
- REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous systemEMORY UNIVERSITY2022–2027
- Host Genetic and Epigenetic Factors of the Progression, Comorbidities and Outcomes of Viral InfectionVETERANS HEALTH ADMINISTRATION2022–2026
- Multi-omic Predictors of Renal Function among HIV-infected Individuals of African AncestryEMORY UNIVERSITY2020–2025
- Integrating HIV and hEART health in South Africa (iHeart-SA)WITS HEALTH CONSORTIUM (PTY), LTD2020–2025
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
